Published in J Urol on August 01, 1989
Effect of pH and osmolality on in vitro phagocytosis and killing by neutrophils in urine. Infect Immun (1993) 0.90
Taurine protects against PMN dysfunction and death in urine. Urol Res (2004) 0.77
Elementary immunology: Na(+) as a regulator of immunity. Pediatr Nephrol (2016) 0.75
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin Med (1994) 2.20
Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis (1992) 1.61
Inhibition of chemiluminescent response of human polymorphonuclear leukocytes by hyperosmolality comparable to renal medulla and preservation by ofloxacin. Eur Urol (1991) 1.60
Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate. Antimicrob Agents Chemother (1989) 1.48
Preventive effect of dapsone on renal scarring following mannose-sensitive piliated bacterial infection. Chemotherapy (1998) 1.41
Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron (1990) 1.41
Renal scarring is enhanced by phorbol myristate acetate following infection with bacteria with mannose-sensitive pili. Nephron (1993) 1.38
Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob Agents Chemother (1995) 1.27
Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Int J Urol (1997) 1.25
Detection of Chlamydia trachomatis in vaginal specimens from female commercial sex workers using a new improved enzyme immunoassay. Sex Transm Infect (1998) 1.16
Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro. Sex Transm Infect (1998) 1.15
Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections. J Antimicrob Chemother (1983) 1.12
Leiomyosarcoma of the kidney: CT and MR appearance. J Comput Assist Tomogr (1993) 1.10
Peripheral neuropathy associated with fluoroquinolones. Lancet (1992) 1.06
Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group. Antimicrob Agents Chemother (1998) 1.06
Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan. Genitourin Med (1994) 1.05
Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux. J Urol (1996) 1.04
Expression of beta3-adrenoceptors in rat detrusor smooth muscle. J Urol (1998) 1.03
Nonspecific granulomatous prostatitis. Urology (1992) 1.01
Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol (1992) 1.00
Renal arteriovenous malformations: CT features. J Comput Assist Tomogr (1991) 0.99
High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in female commercial sex workers in Japan. Int J STD AIDS (2000) 0.98
Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan. J Urol (1998) 0.97
Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma. J Surg Oncol (2001) 0.97
In vitro activity of enoxacin compared with norfloxacin and amikacin. Eur J Clin Microbiol (1985) 0.95
Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res (1994) 0.93
Laparoscopic adrenalectomy: comparison with open adrenalectomy. Eur Urol (1994) 0.90
Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br J Cancer (1995) 0.89
Trends in sexually transmitted diseases and condom use patterns among commercial sex workers in Fukuoka City, Japan 1990-93. Genitourin Med (1996) 0.89
Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue. J Urol (1987) 0.88
Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study. Int J Urol (2001) 0.87
Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection. Immunology (1994) 0.87
Reduced chlamydial infection and gonorrhea among commercial sex workers in Fukuoka City, Japan. Int J Urol (1998) 0.86
Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract. Eur Urol (1992) 0.85
Identification and nucleotide sequence of the gene determining the adhesion capacity of Serratia marcescens. J Bacteriol (1991) 0.85
Neutrophil function in hyperosmotic NaCl is preserved by phosphoenol pyruvate. Urol Res (1991) 0.85
Chlamydia trachomatis antigen can be detected in the urine sample of men with non-gonococcal urethritis. Urol Res (1991) 0.85
Increased renal scarring by bacteria with mannose-sensitive pili. Urol Res (1990) 0.85
Complications of laparoscopic and retroperitoneoscopic adrenalectomies in 370 cases in Japan: a multi-institutional study. Biomed Pharmacother (2000) 0.84
Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study. Cancer (1995) 0.84
Leiomyosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations. Hum Pathol (1998) 0.84
Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy. Urol Int (1991) 0.84
Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats. Pharmacol Toxicol (1992) 0.84
Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Kyushu University Urological Oncology Group. Int J Urol (1997) 0.83
Significance of urinary endotoxin concentration in patients with urinary tract infection. Urol Res (1991) 0.83
Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae. Genitourin Med (1996) 0.83
Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol (1996) 0.83
Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer. Prostate (1999) 0.83
Estimate criteria for diagnosis and severity in benign prostatic hyperplasia. Int J Urol (1996) 0.82
Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group. Cancer Chemother Pharmacol (1992) 0.82
Ultrastructural studies of adrenal adenoma causing primary aldosteronism. Virchows Arch A Pathol Anat Histopathol (1985) 0.81
Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol (1994) 0.81
Effect of pili of Serratia marcescens on superoxide production and phagocytosis of human polymorphonuclear leukocytes. J Urol (1995) 0.81
Effects of Y-26763, a novel K-channel opener, on electrical responses of smooth muscles in the guinea pig bladder. J Urol (1996) 0.81
Role of superoxide in renal scarring following infection by mannose-sensitive piliated bacteria. Urol Res (1991) 0.81
An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients. J Urol (1993) 0.81
A flow cytometric analysis of the expression of adhesion molecules on human renal cell carcinoma cells with different metastatic potentials. Eur Urol (1997) 0.80
Distribution of a methicillin-resistance gene in urinary isolates of methicillin-resistant staphylococci examined by enzymatic detection of the polymerase chain reaction. Chemotherapy (1997) 0.80
Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance. Oncol Res (1998) 0.80
Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group. Jpn J Clin Oncol (1999) 0.80
Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study. Urol Int (1992) 0.80
Influence of strain, biomaterial, proteins, and oncostatic chemotherapy on Staphylococcus epidermidis adhesion to intravascular catheters in vitro. J Lab Clin Med (1996) 0.79
Establishment of two human renal cell carcinoma cell lines with different chemosensitivity. Hum Cell (1996) 0.79
A retroperitoneal bronchogenic cyst treated with laparoscopic surgery. J Urol (1997) 0.79
Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group. Cancer Chemother Pharmacol (1998) 0.79
Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria. Int J Urol (1999) 0.79
Influence of hyperosmotic environment comparable to the renal medulla upon membrane NADPH oxidase of human polymorphonuclear leukocytes. J Urol (1994) 0.79
Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract. Eur Urol (1991) 0.79
Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria. Nephron (1992) 0.79
[Current status and problems of a screening for prostatic cancer in the health facilities in Fukuoka Prefecture]. Nihon Hinyokika Gakkai Zasshi (1993) 0.79
Cell-mediated autoimmune response to testis induced by bilateral testicular injury can be suppressed by cyclosporin A. J Urol (1998) 0.78
Infectious complications of combination anticancer chemotherapy for urogenital cancers. Int Urol Nephrol (1999) 0.78
Clinical significance of urinary enzymes and beta 2-microglobulin following ESWL. Int Urol Nephrol (1994) 0.78
Fleroxacin enhancement of superoxide production by polymorphonuclear leukocytes: the role of protein kinases. Chemotherapy (1997) 0.78
p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas. Mod Pathol (1997) 0.78
Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma. Eur Urol (1993) 0.78
Testicular injury induces cell-mediated autoimmune response to testis. J Urol (1995) 0.78
Establishment and characterization of two human bladder cancer cell lines. Hum Cell (1996) 0.78
In-vitro activity of fleroxacin (Ro 23-6240), a new fluoro-quinolone, and other agents, against Mycobacterium spp. J Antimicrob Chemother (1988) 0.78
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group]. Gan To Kagaku Ryoho (1997) 0.78
Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa. J Antimicrob Chemother (1996) 0.78
The mechanism of relaxation induced by atrial natriuretic peptide in the porcine renal artery. Br J Pharmacol (1996) 0.77
Suppression of chemotactic activity of neutrophils in hyperosmotic conditions comparable to the renal medulla: partial preservation by phosphoenolpyruvate. Urol Int (1993) 0.77
Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. Nephron (1995) 0.77
Direct inactivation of human polymorphonuclear leukocyte by hyperosmotic urea comparable to the renal medulla. J Urol (1993) 0.77
The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors. Int J Urol (1996) 0.77